![Chronic Obstructive Pulmonary Disorder Chronic Obstructive Pulmonary Disorder](https://assets.delveinsight.com/blog/wp-content/uploads/2017/02/15171738/COPD-scaled.jpg)
DelveInsight Blog
Related Article
![pharma-news-for-eli-lilly-ideaya-roche-sanofi pharma-news-for-eli-lilly-ideaya-roche-sanofi](https://assets.delveinsight.com/blog/wp-content/uploads/2024/07/09162838/pharma-news-for-eli-lilly-ideaya-roche-sanofi.png)
Lilly’s Morphic Acquisition; IDEAYA’s IDE397 Positive Phase II Trial Result; XPOVIO (selinexor) Approval in China; Roche to Reintroduce Susvimo in the US; Dupixent EU Approval
Lilly Strengthens IBD Treatment Portfolio with Morphic Acquisition Eli Lilly and Company and Morphic Holding, Inc. announced a definitive agreement for Lilly to acquire Morphic, a biopharmaceutical company developing oral integrin therapies for serious chronic diseases. Lilly will initiate a tender offer to acqu...
Find More![pharma-news-for-eisai-merck-verona-astrazeneca pharma-news-for-eisai-merck-verona-astrazeneca](https://assets.delveinsight.com/blog/wp-content/uploads/2024/07/02110054/pharma-news-for-eisai-merck-verona-astrazeneca.png)
Eisai Announces Solo Development of Farletuzumab Ecteribulin (FZEC); Johnson & Johnson’s Nipocalimab Phase III Trial; Merck’s WINREVAIR EU CHMP Recommendation; Verona Pharma’s Ohtuvayre FDA Approval; AstraZeneca’s Lynparza and Imfinzi EU Approval
Eisai Announces Solo Venture for Farletuzumab Ecteribulin (FZEC) Antibody Drug Conjugate Eisai Co., Ltd. announced the termination of its global strategic collaboration with Bristol Myers Squibb for the co-development and co-commercialization of farletuzumab ecteribulin (FZEC), previously known as MORAb-202, an ...
Find More![Airway Management Devices Market Insights Airway Management Devices Market Insights](https://assets.delveinsight.com/blog/wp-content/uploads/2024/01/24141621/airway-management-devices-market-trends-and-innovations.png)
Airway Management Devices: Charting the Evolving Market Trends and Key Innovations
Technological evolution has significantly transformed Airway Management Devices in recent years, ushering in a new era of efficiency, precision, and patient safety. Advances in materials, design, and manufacturing processes have led to the development of more sophisticated devices. Moreover, the incorporation of hi...
Find MoreEditor's Pick
Newsletter/Whitepaper
Recent Article
ASCO Conference 2024
![ASCO 2023 ASCO 2023](https://assets.delveinsight.com/img/events/american-society-of-clinical-oncology-conference-2024.png)
Live Coverage of ASCO 2024 Visit Now for Real-Time Insights and Analytical, Impactful Updates!